Expert consensus on the use of omalizumab in chronic urticaria in China
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Expert consensus on the use of omalizumab in chronic urticaria in China
Authors
Keywords
Chronic spontaneous urticaria, Chronic inducible urticaria, Treatment algorithm, Omalizumab, China
Journal
World Allergy Organization Journal
Volume 14, Issue 11, Pages 100610
Publisher
Elsevier BV
Online
2021-12-06
DOI
10.1016/j.waojou.2021.100610
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Omalizumab treatment and outcomes in Chinese patients with chronic spontaneous urticaria, chronic inducible urticaria, or both
- (2021) Yudi Chen et al. World Allergy Organization Journal
- Omalizumab in chronic inducible urticaria: A real‐life study of efficacy, safety, predictors of treatment outcome and time to response
- (2021) Miao Yu et al. CLINICAL AND EXPERIMENTAL ALLERGY
- Update on omalizumab in allergen immunotherapy
- (2021) Jennifer A. Dantzer et al. Current Opinion in Allergy and Clinical Immunology
- Addition of omalizumab to antihistamine treatment in chronic urticaria
- (2020) Yu-Di Chen et al. ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY
- Omalizumab in children and adolescents with chronic spontaneous urticaria: Case series and review of the literature
- (2020) Stefano Passanisi et al. Dermatologic Therapy
- Omalizumab Re-Treatment and Step-Up in Patients with Chronic Spontaneous Urticaria: OPTIMA Trial
- (2020) Gordon Sussman et al. Journal of Allergy and Clinical Immunology-In Practice
- Omalizumab for the treatment of Chronic Inducible Urticaria in 80 patients
- (2020) V. Exposito‐Serrano et al. BRITISH JOURNAL OF DERMATOLOGY
- Antihistamine‐resistant chronic spontaneous urticaria remains undertreated: 2‐year data from the AWARE study
- (2020) M Maurer et al. CLINICAL AND EXPERIMENTAL ALLERGY
- Efficacy and tolerability of the updosing of second‐generation non‐sedating H1 antihistamines in children with chronic spontaneous urticaria
- (2020) Lucrezia Sarti et al. PEDIATRIC ALLERGY AND IMMUNOLOGY
- Omalizumab concentrations in pregnancy and lactation: A case study
- (2020) Jumpei Saito et al. Journal of Allergy and Clinical Immunology-In Practice
- Validation of the Angioedema Control Test (AECT)—A Patient-Reported Outcome Instrument for Assessing Angioedema Control
- (2020) Karsten Weller et al. Journal of Allergy and Clinical Immunology-In Practice
- The global burden of chronic urticaria for the patient and society
- (2020) M. Gonçalo et al. BRITISH JOURNAL OF DERMATOLOGY
- Efficacy of omalizumab treatment for pediatric chronic spontaneous urticaria: A multi‐center retrospective case series
- (2020) Anne Ari et al. PEDIATRIC DERMATOLOGY
- Omalizumab in children and adolescents with chronic urticaria: A 16‐week real‐world study
- (2020) Xiao‐ting Song et al. ALLERGY
- Efficacy and safety of omalizumab (Xolair®) for cholinergic urticaria in patients unresponsive to a double dose of antihistamines: a randomized mixed double-blind and open-label placebo-controlled clinical trial
- (2019) Gabriel Gastaminza et al. Journal of Allergy and Clinical Immunology-In Practice
- Omalizumab for Chronic Urticaria in Children Less than 12 Years of Age: A Systematic Review.
- (2019) Taha Al-Shaikhly et al. ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY
- Pregnancy Outcomes in the Omalizumab Pregnancy Registry and a Disease-matched Comparator Cohort
- (2019) Jennifer A. Namazy et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- The Real-Life Effectiveness and Safety of Omalizumab Updosing in Patients With Chronic Spontaneous Urticaria
- (2019) Andac Salman et al. JOURNAL OF CUTANEOUS MEDICINE AND SURGERY
- Biomarkers and clinical characteristics of autoimmune chronic spontaneous urticaria: Results of the PURIST Study
- (2019) Nicole Schoepke et al. ALLERGY
- How to treat patients with chronic spontaneous urticaria with omalizumab: Questions and answers
- (2019) Murat Türk et al. Journal of Allergy and Clinical Immunology-In Practice
- Update on Atopic Dermatitis
- (2019) Tiago Torres et al. Acta Medica Portuguesa
- Prevalence of chronic urticaria in children and adults across the globe: systematic review with meta‐analysis
- (2019) Julia Fricke et al. ALLERGY
- Angioedema Activity Score (AAS): A Valid and Reliable Tool to Use in Asian Patients
- (2019) Kanokvalai Kulthanan et al. Biomed Research International
- Sexual Functioning Is Frequently and Markedly Impaired in Female Patients with Chronic Spontaneous Urticaria
- (2019) Ragıp Ertaş et al. Journal of Allergy and Clinical Immunology-In Practice
- Development of the Angioedema Control Test—A patient‐reported outcome measure that assesses disease control in patients with recurrent angioedema
- (2019) Karsten Weller et al. ALLERGY
- Long-term combinations and updosing of second-generation H1-antihistamines show efficacy and safety in the treatment of chronic spontaneous urticaria: A multicenter real-life pilot study
- (2019) Liming Zhang et al. Journal of Allergy and Clinical Immunology-In Practice
- The EAACI/GA²LEN/EDF/WAO guideline for the definition, classification, diagnosis and management of urticaria
- (2018) T. Zuberbier et al. ALLERGY
- Update on Omalizumab for Urticaria: What’s New in the Literature from Mechanisms to Clinic
- (2018) Désirée E. S. Larenas-Linnemann et al. CURRENT ALLERGY AND ASTHMA REPORTS
- Effectiveness of omalizumab in adolescent and adult patients with chronic idiopathic/spontaneous urticaria: a systematic review of ‘real-world’ evidence
- (2018) Jonathan A. Bernstein et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Omalizumab treatment in patients with chronic inducible urticaria: A systematic review of published evidence
- (2018) Marcus Maurer et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Prevalence and clinical characteristics of chronic spontaneous urticaria in pediatric patients
- (2018) Maria-Magdalena Balp et al. PEDIATRIC ALLERGY AND IMMUNOLOGY
- The effect of omalizumab treatment on severe allergic asthma and allergic comorbidities: real-life experience from the Czech Anti-IgE Registry
- (2018) Beáta Hutyrová et al. Postepy Dermatologii i Alergologii
- Treatment and retreatment with omalizumab in chronic spontaneous urticaria: Real life experience with twenty-five patients
- (2018) Murat Türk et al. ALLERGOLOGY INTERNATIONAL
- Omalizumab is effective in symptomatic dermographism—results of a randomized placebo-controlled trial
- (2017) Marcus Maurer et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Omalizumab is effective in cold urticaria—results of a randomized placebo-controlled trial
- (2017) Martin Metz et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Increased IgE levels are linked to faster relapse in patients with omalizumab-discontinued chronic spontaneous urticaria
- (2017) Ragip Ertas et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Autoimmune chronic spontaneous urticaria: What we know and what we do not know
- (2017) Pavel Kolkhir et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Management of chronic inducible urticaria according to the guidelines: A prospective controlled study
- (2017) Emek Kocatürk et al. JOURNAL OF DERMATOLOGICAL SCIENCE
- Epidemiology and comorbidities of patients with chronic urticaria in Korea: A nationwide population-based study
- (2017) Bo Ri Kim et al. JOURNAL OF DERMATOLOGY
- Omalizumab as Third-Line Therapy for Urticaria During Pregnancy
- (2017) LF Ensina et al. JOURNAL OF INVESTIGATIONAL ALLERGOLOGY AND CLINICAL IMMUNOLOGY
- Beneficial effects of Omalizumab therapy in allergic bronchopulmonary aspergillosis: A synthesis review of published literature
- (2017) Jian-Xiong Li et al. RESPIRATORY MEDICINE
- Omalizumab for severe chronic spontaneous urticaria: Real-life experiences of 280 patients
- (2017) Zahava Vadasz et al. Journal of Allergy and Clinical Immunology-In Practice
- The Angioedema Quality of Life Questionnaire (AE-QoL) - assessment of sensitivity to change and minimal clinically important difference
- (2016) K. Weller et al. ALLERGY
- The definition, diagnostic testing, and management of chronic inducible urticarias - The EAACI/GA2LEN/EDF/UNEV consensus recommendations 2016 update and revision
- (2016) M. Magerl et al. ALLERGY
- Definition, aims, and implementation of GA2LEN Urticaria Centers of Reference and Excellence
- (2016) M. Maurer et al. ALLERGY
- Efficacy of omalizumab in patients with atopic dermatitis: A systematic review and meta-analysis
- (2016) Hsiao-Han Wang et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Omalizumab for the treatment of chronic spontaneous urticaria: A meta-analysis of randomized clinical trials
- (2016) Zuo-Tao Zhao et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Omalizumab use during pregnancy for chronic spontaneous urticaria (CSU): report of two cases
- (2016) M. González-Medina et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- The Xolair Pregnancy Registry (EXPECT): The safety of omalizumab use during pregnancy
- (2015) Jennifer Namazy et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Efficacy and Safety of Omalizumab in Patients with Chronic Idiopathic/Spontaneous Urticaria who Remain Symptomatic on H 1 Antihistamines: A Randomized, Placebo-Controlled Study
- (2015) Sarbjit S. Saini et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Similar Efficacy with Omalizumab in Chronic Idiopathic/Spontaneous Urticaria Despite Different Background Therapy
- (2015) Thomas B. Casale et al. Journal of Allergy and Clinical Immunology-In Practice
- Development and validation of the Urticaria Control Test: A patient-reported outcome instrument for assessing urticaria control
- (2014) Karsten Weller et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Retreatment With Omalizumab Results in Rapid Remission in Chronic Spontaneous and Inducible Urticaria
- (2014) Martin Metz et al. JAMA Dermatology
- Omalizumab vs. placebo in the management of chronic idiopathic urticaria: a systematic review
- (2014) Diana C Carrillo et al. World Allergy Organization Journal
- Chronic urticaria in Chinese population: a hospital-based multicenter epidemiological study
- (2013) H. Zhong et al. ALLERGY
- Omalizumab for the Treatment of Chronic Idiopathic or Spontaneous Urticaria
- (2013) Marcus Maurer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Life quality of Chinese patients with chronic urticaria as assessed by the dermatology life quality index
- (2011) J.-B. Liu et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Experience with Cyclosporine in Children with Chronic Idiopathic Urticaria
- (2009) Devang R. Doshi et al. PEDIATRIC DERMATOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started